Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.250 +0.010 (+0.81%)
Streaming Delayed Price Updated: 11:13 AM EDT, Sep 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,548,158
Open 1.260
Bid (Size) 1.240 (20,200)
Ask (Size) 1.250 (23,700)
Prev. Close 1.240
Today's Range 1.230 - 1.270
52wk Range 1.040 - 2.010
Shares Outstanding 508,766,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Klotho Protein Emerges as a Potential Powerhouse In the Next Generation of Longevity Medicine
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:BIOA),(NASDAQ:GERN),(NASDAQ:DNLI) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Geron Eyes High End of 2026 RYTELO Revenue Guidance as Community Adoption Expands ↗
Geron (NASDAQ:GERN) executives said the company remains on track to generate 2026 RYTELO net revenue of $220 million to $240 million, with Chief Executive Officer Harout Semerjian saying the company... 
Via MarketBeat

Performance

YTD
-5.3%
-5.3%
1 Month
-16.1%
-16.1%
3 Month
-2.3%
-2.3%
6 Month
-16.1%
-16.1%
1 Year
-4.6%
-4.6%

More News

Read More
News headline image
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
From Kahn Swick & Foti, LLC
Via Business Wire
Geron (NASDAQ:GERN) Falls After Mixed Q2 Results; Revenue Beats but Loss Wider Than Expected ↗
Via Chartmill
Geron Corp. (NASDAQ:GERN) Beats Q1 Estimates as RYTELO Sales Momentum Continues ↗
Via Chartmill
Geron Corp (NASDAQ:GERN) Stock Plummets 10% After Q4 Revenue Miss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
Via Benzinga
News headline image
Geron Earnings Preview ↗
Via Benzinga
News headline image
Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands ↗
Via MarketBeat
News headline image
Geron (GERN) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Geron Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
Via FinancialNewsMedia
News headline image
Geron (GERN) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings Economy
News headline image
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
Via FinancialNewsMedia
Here are the top movers in Wednesday's session. ↗
Via Chartmill
News headline image
Geron (GERN) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
Which stocks are moving before the opening bell on Wednesday? ↗
Via Chartmill
News headline image
Why Did GERN Stock Tumble 10% Pre-Market Today? ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates ↗
Via Chartmill
News headline image
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
From Geron Corporation
Via Business Wire
News headline image
Geron Corporation to Present at Upcoming Investor Conferences
From Geron Corporation
Via Business Wire
News headline image
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
From Geron Corporation
Via Business Wire
News headline image
Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025
From Geron Corporation
Via Business Wire
News headline image
GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire

Frequently Asked Questions

Is Geron Corporation - Common Stock publicly traded?
Yes, Geron Corporation - Common Stock is publicly traded.
What exchange does Geron Corporation - Common Stock trade on?
Geron Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Geron Corporation - Common Stock?
The ticker symbol for Geron Corporation - Common Stock is GERN on the Nasdaq Stock Market
What is the current price of Geron Corporation - Common Stock?
The current price of Geron Corporation - Common Stock is 1.250
When was Geron Corporation - Common Stock last traded?
The last trade of Geron Corporation - Common Stock was at 09/30/26 11:13 AM ET
What is the market capitalization of Geron Corporation - Common Stock?
The market capitalization of Geron Corporation - Common Stock is 635.96M
How many shares of Geron Corporation - Common Stock are outstanding?
Geron Corporation - Common Stock has 636M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.